Differentiated thyroid cancers

Czech version

Authors: Kateřina Táborská
Authors‘ workplace: Klinika nukleární medicíny a endokrinologie, 2. LF UK a FN v Motole, Praha
Published in: NuklMed 2014;3:44
Category: Editorial

Sources

1. Pellegriti G, Frasca F, Regalbuto C et al. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. Journal of Cancer Epidemiology [online]. 2013. [cit. 2014-01-08] ]. Dostupné na: http://dx.doi.org/10.1155/2013/96521

2. Seidlin SM, Marinell LD, Oshry E. Radioactive iodine therapy: Effect on Functioning Metastases of Adenocarcinoma of the Thyroid. JAMA 1946;132:838-847

3. Pacini F, Schlumberger M, Dralle H et al. European consensus for management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803

4. Schlumberger M, Catargi B, Borget I et al. Strategies of radioidine ablation in patients with low risk thyroid cancer. The New England Journal of Medicine 2012;366:1663-1673

5. Bendlová B, Dvořáková Š, Sýkorová V et al. Genetika nádorů štítné žlázy a jejich molekulárně cílená léčba. Onkologie 2011;5:325-329

Labels

Nuclear medicine Radiodiagnostics Radiotherapy

Quantification of cerebrovascular reserve in patients with cerebrovascular disease – is there still a role for scintigraphy?

Determination of cerebrovascular reserve using dipyridamole and brain SPECT

Treatment of patient with accumulating skull metastases in thyroid cancer

What can you see on the image?

Article was published in

Nuclear Medicine

2014 Issue 3